We are live on ! Find out more
CSCI

COSCIENS Biopharma Inc. Common Stock
CSCI

Delisted

CSCI was delisted on the 3rd of September, 2025.

Back to rankings

15 hedge funds and large institutions have $56.9K invested in COSCIENS Biopharma Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 1

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

67% more funds holding

Funds holding: 9 → 15 (+6)

0.14% more ownership

Funds ownership: 0.53% → 0.67% (+0.14%)

8% less capital invested

Capital invested by funds: $61.9K → $56.9K (-$5K)

Holders
15
Holders Change
+6
Holders Change %
+66.67%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
2
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$4.59K
2
MCM
MAI Capital Management
Ohio
+$3.75K
3
Citigroup
Citigroup
New York
+$2.94K
4
UBS Group
UBS Group
Switzerland
+$2.24K
5
Morgan Stanley
Morgan Stanley
New York
+$1.3K

Top Sellers

Rank Fund Capital Flow
1
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$2.16K
2
DB
Danske Bank
Denmark
-$7
Name Holding Trade Value Shares
Change 		Change in
Stake
National Bank of Canada
1
National Bank of Canada
Quebec, Canada
$15.9K +$404 +124 +2%
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$11K +$4.59K +1,409 +56%
FDCDDQ
3
Federation des caisses Desjardins du Quebec
Quebec, Canada
$10.3K -$2.16K -663 -15%
TWC
4
TD Waterhouse Canada
Ontario, Canada
$9.94K – – –
MCM
5
MAI Capital Management
Ohio
$3.09K +$3.75K +1,151 New
Citigroup
6
Citigroup
New York
$2.42K +$2.94K +902 New
UBS Group
7
UBS Group
Switzerland
$1.9K +$2.24K +686 New
Morgan Stanley
8
Morgan Stanley
New York
$1.11K +$1.3K +400 New
SS
9
SBI Securities
Japan
$457 +$538 +165 New
BNP Paribas Financial Markets
10
BNP Paribas Financial Markets
France
$271 +$326 +100 New
Osaic Holdings
11
Osaic Holdings
Arizona
$134 – – –
TRCT
12
Tower Research Capital (TRC)
New York
$105 – – –
Group One Trading
13
Group One Trading
Illinois
$100 +$121 +37 New
TC
14
Truvestments Capital
Florida
$61 – – –
GLF
15
Groupe la Francaise
France
$8 +$3 +1 New
DB
16
Danske Bank
Denmark
– -$7 -2 Closed

CSCI Hedge Fund Activity: Q4 2024 in Review

15 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in COSCIENS Biopharma Inc. Common Stock (CSCI) for Q4 2024, worth a combined $56.9K — down 8.1% from $61.9K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new CSCI positions and 1 closed out — a net gain of 7 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Royal Bank of Canada, adding an estimated $4.59K. The largest seller was Federation des caisses Desjardins du Quebec, cutting an estimated $2.16K.

  • 15 institutional investors held COSCIENS Biopharma Inc. Common Stock (CSCI) as of Q4 2024, up from 9 in Q3 2024.
  • Funds reported $56.9K of COSCIENS Biopharma Inc. Common Stock stock for Q4 2024, down 8.1% quarter-over-quarter.
  • 8 funds opened new COSCIENS Biopharma Inc. Common Stock positions in Q4 2024 and 1 closed out, a net change of +7 holders.
  • The largest COSCIENS Biopharma Inc. Common Stock buyer in Q4 2024 was Royal Bank of Canada, an estimated $4.59K added.
  • The largest COSCIENS Biopharma Inc. Common Stock seller in Q4 2024 was Federation des caisses Desjardins du Quebec, an estimated $2.16K sold.

Based on aggregated 13F filings for Q4 2024.